Heartflow, Inc. (Ticker: HTFL US) is a U.S. company specializing in AI-powered software for the non-invasive diagnosis and management of coronary artery disease (CAD). Heartflow plans to list on the NASDAQ on August 8, 2025. The company is offering 12.5 million shares at a price range of $15.00 to $17.00, aiming to raise approximately $200 million. The IPO is expected to give the company a market capitalization of around $1.24 billion. Proceeds will reportedly be used for working capital and general corporate purposes. Heartflow's platform creates personalized 3D heart models from CCTA scans to quantify blood flow and assess plaque. The offering is led by J.P. Morgan and Morgan Stanley.